Aviva India’s CIO Balamurugan Shanmugam discusses market volatility driven by tariff uncertainties and offers insights into the earnings landscape post Q2. He highlights that while domestic investors remain active, Aviva is sidestepping the soaring IPO valuations, believing the secondary market presents better long-term opportunities.Read More

Investors are reassessing portfolios for 2026. Real estate is a strategic, measured component. Property should be a satellite allocation, ideally 10-15% of a portfolio. REITs and managed structures will drive stable income. Equities lead wealth creation, fixed income provides stability. Real estate complements core financial strategies. Tier-2 cities offer superior income and growth opportunities.Read More

Mphasis shares are expected to see significant movement on Tuesday, November 18. Promoter Blackstone is looking to sell a substantial stake of up to 9.5% through block deals. The floor price is set at Rs 2,570 per share. This transaction is estimated to be worth around Rs 4,626 crore. Blackstone previously reduced its holding in...Read More

Post ContentRead More

Eternal (formerly Zomato) shares dipped slightly despite Morgan Stanley raising its target price to Rs 427, citing an attractive buying window after a recent correction. The brokerage believes the company’s market share gains are positive, with limited downside risk even in a stress scenario. Despite a 63% year-on-year profit decline, revenue surged 183%.Read More

Foreign institutional investors reduced stakes in several Indian defence stocks during the September quarter, citing valuation concerns and slower-than-expected order inflows. Despite this pullback, mutual funds showed increased buying interest, indicating a selective shift in investor preference within the sector.Read More

Indian stocks opened lower on Tuesday, snapping a six-day winning streak. Both the Sensex and Nifty saw declines as investors adopted a cautious stance. This pullback comes ahead of key U.S. economic data that could influence the Federal Reserve’s decision on interest rates next month.Read More

AstraZeneca Pharma India shares may be in focus after the company announced a second brand partnership with Sun Pharma to expand nationwide access to Sodium Zirconium Cyclosilicate (SZC), a therapy for managing hyperkalemia. Under the agreement, both companies will promote, market and distribute SZC under separate brands to accelerate patient access to what AstraZeneca calls...Read More

Gold and silver prices declined on 18 November amid reduced expectations of a US interest rate cut. On the MCX, December gold futures fell to Rs 1,21,466 per 10 grams, while silver slipped to Rs 1,52,750 per kilogram. Fed officials’ cautious stance and delayed US economic data have lowered hopes of a rate cut in...Read More

Post ContentRead More